text: <unk>  is a antipsychotic agent that is FDA approved for the treatment of chronic schizophrenia.   Common adverse reactions include hypotension, orthostatic hypotension, diminished sweating, photosensitivity, constipation, xerostomia, akathisia, dizziness, drug-induced tardive dystonia, dystonia, extrapyramidal disease, parkinsonian, somnolence, tardive dyskinesia, blurred vision, epithelial keratopathy, eye / vision finding, retinitis pigmentosa, nasal congestion.
option_0: Fluphenazine
option_1: Carisbamate
option_2: Nabilone
option_3: Perphenazine
option_4: Disulfiram
option_5: Cinolazepam
option_6: Suvorexant
option_7: Fenquizone